FDA clears Lumenis' IPL (Intense Pulsed Light) technology for rosacea:
This article was originally published in Clinica
Lumenis has received US FDA 510(k) clearance to market its Intense Pulsed Light (IPL) technology as a treatment for hyperpigmentation and erythaema (redness) associated with the skin condition rosacea. IPL supplies high levels of non-laser light power in precision-measured pulses, controlled down to the ten-thousandth of a second. The Santa Clara, California firm says that according to the American Academy of Dermatology, around 13 million people in the US suffer from rosacea.